PubRank

André Delacourte

Author PubWeight™ 78.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007 18.62
2 Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 2010 8.74
3 Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A 2008 5.24
4 The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science 2009 2.35
5 Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 2004 2.15
6 MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 2008 1.89
7 Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. J Neurochem 2003 1.40
8 Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J Biol Chem 2007 1.35
9 Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc Natl Acad Sci U S A 2007 1.30
10 Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J Clin Endocrinol Metab 2002 1.25
11 Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. Biochim Biophys Acta 2003 1.24
12 Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol Ther 2009 1.23
13 Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005 1.21
14 Biochemistry of Tau in Alzheimer's disease and related neurological disorders. Expert Rev Proteomics 2008 1.21
15 Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem 2003 1.17
16 p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death. J Cell Sci 2005 1.15
17 Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. J Biol Chem 2003 1.10
18 Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia. Arch Neurol 2007 1.04
19 Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a gamma-secretase-dependent mechanism. Neurobiol Dis 2005 1.03
20 Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol Dis 2007 1.02
21 Pin1 allows for differential Tau dephosphorylation in neuronal cells. Mol Cell Neurosci 2006 1.02
22 ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I. J Neurosci Res 2006 1.01
23 Pathological determinants of the transition to clinical dementia in Alzheimer's disease. Exp Aging Res 2002 1.00
24 BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease. Int J Med Sci 2007 0.97
25 Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease. Neurobiol Aging 2007 0.96
26 Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease. J Neurochem 2002 0.92
27 Expression of human FE65 in amyloid precursor protein transgenic mice is associated with a reduction in beta-amyloid load. J Neurochem 2005 0.91
28 Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem 2002 0.91
29 In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Res 2003 0.90
30 Retinoic acid normalizes nuclear receptor mediated hypo-expression of proteins involved in beta-amyloid deposits in the cerebral cortex of vitamin A deprived rats. Neurobiol Dis 2006 0.90
31 Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. J Biol Chem 2009 0.89
32 Phosphorylated serine 199 of microtubule-associated protein tau is a neuronal epitope abundantly expressed in youth and an early marker of tau pathology. Acta Neuropathol 2002 0.89
33 Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol 2002 0.88
34 Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiol Dis 2007 0.87
35 Functional characterization of FTDP-17 tau gene mutations through their effects on Xenopus oocyte maturation. J Biol Chem 2001 0.85
36 Association study of three polymorphisms of kinesin light-chain 1 gene with Alzheimer's disease. Neurosci Lett 2004 0.84
37 A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Brain 2004 0.84
38 Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies. Ann N Y Acad Sci 2003 0.82
39 Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiol Dis 2004 0.81
40 Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process. Neurosci Lett 2004 0.81
41 Pin1: a therapeutic target in Alzheimer neurodegeneration. J Mol Neurosci 2002 0.80
42 Neurofibrillary degeneration of the Alzheimer-type: an alternate pathway to neuronal apoptosis? Biochem Pharmacol 2003 0.80
43 O-GlcNAc glycosylation and neurological disorders. Adv Exp Med Biol 2003 0.79
44 Diffuse form of argyrophilic grain disease: a new variant of four-repeat tauopathy different from limbic argyrophilic grain disease. Acta Neuropathol 2003 0.79
45 Hypertension and progressive supranuclear palsy: is everything so clear? Mov Disord 2004 0.79
46 Effects of Abeta1-42 fibrils and of the tetrapeptide Pr-IIGL on the phosphorylation state of the tau-protein and on the alpha7 nicotinic acetylcholine receptor in vitro. Eur J Neurosci 2005 0.78
47 Association of corticobasal degeneration and Huntington's disease: can Tau aggregates protect Huntingtin toxicity? Mov Disord 2009 0.78
48 Sp3 and sp4 transcription factor levels are increased in brains of patients with Alzheimer's disease. Neurodegener Dis 2007 0.78
49 [Tauopathy and Alzheimer disease: a full degenerating process]. Psychol Neuropsychiatr Vieil 2006 0.76
50 Pathological determinants of dementia in Alzheimer's disease (AD). Exp Aging Res 2003 0.75
51 [Tau story: from frontotemporal dementia to other tauopathies]. J Soc Biol 2002 0.75